Contract award · 27 Aug 2025

NP47725a Emicizumab (Indication Specific)

The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) awarded a contract to Roche Products Ltd for £3.12m. Awarded…

No competitionMedical equipment & pharmaceuticalsScotland

Awarded without open competition

Awarded without open competition. The buyer went directly to one or a few suppliers instead of advertising the contract. Procurement rules allow this only in specific cases, such as extreme urgency, when only one supplier can do the work, or for call-offs from an existing framework.

What “without competition” means

Key facts

Value
£3,120,312
Procedure
Negotiated without publication of a contract notice
Sector
Medical equipment & pharmaceuticals · Pharmaceutical products (CPV 33600000)
Region
Scotland
Timeline
  1. Contract date27 Aug 2025
  2. Published18 Sep 2025Published 22 days after the contract date

Description

The Framework Agreement is for the supply of Emicizumab (Indication Specific) to NHS Scotland. The Framework Agreement has been awarded as a single supplier framework agreement to one (1) Framework Participant.

About the supplier

Other awards in the same procurement

Call-offs and awards published under the same process (for example a framework or dynamic purchasing system).

Date Contract Supplier Value
27 Aug 2025 Roche Products Ltd £3.12m

More from The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

All contracts

More won by Roche Products Ltd

All contracts

Recent medical equipment & pharmaceuticals contracts

Sector overview